方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 肝硬化Child-Pugh评分× | Harvey-Bradshaw指数× | |
|---|---|---|
| 领域 | 胃肠病学 | 胃肠病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1964 (Child-Turcotte), 1973 (Pugh modification) | 1980 |
| 提出者≠ | Child, C. G., Turcotte, J. G., and Pugh, R. N. | R. F. Harvey and J. M. Bradshaw |
| 类型 | Clinician-rated | Clinician-rated |
| 开创性文献≠ | Child, C. G., & Turcotte, J. G. (1964). Surgery and portal hypertension. In C. G. Child (Ed.), The liver and portal hypertension (pp. 50–64). Saunders. link ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| 别名≠ | Child-Turcotte-Pugh Score, CTP Score | HBI |
| 相关≠ | 4 | 5 |
| 摘要≠ | The Child-Pugh Score (originally Child-Turcotte, modified by Pugh in 1973) is a clinical scoring system that stratifies the severity of liver cirrhosis and predicts surgical mortality and prognosis. The score integrates five readily available clinical and laboratory parameters: bilirubin, albumin, prothrombin time (INR), ascites, and hepatic encephalopathy. With a total range of 5–15 points, the Child-Pugh Score is stratified into Class A (mild, 5–6 points), Class B (moderate, 7–9 points), and Class C (severe, 10–15 points), each with distinct mortality predictions. | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGate数据集 ↗ |
|
|